If you or a family member took Actos or an associated drug (ActoPlus Met XR, Duetact, or ActoPlus Met) and developed bladder cancer, you may be eligible for compensation. The corporation that makes Actos, Takeda Pharmaceutical Co., was aware of Actos’ link to bladder cancer but did not notify the FDA until years after it had made billions of dollars off the diabetes drug.
If you or someone you love took Actos and was diagnoses with bladder cancer, please contact our experienced, compassionate attorneys to receive a free case evaluation. Because time limits apply to filing an Actos bladder cancer claim, we recommend contacting us as soon as possible for a free, confidential consultation.
Actos lawsuits are based upon a variety of legal claims including:
Takeda Pharmaceuticals, the company that makes and sells Actos (pioglitazone is the drug’s actual name), which is a drug intended to treat type 2 diabetes. In 2011, the FDA announced that using Actos for more than a year may be linked with a higher risk of bladder cancer. In April 2014, a Louisiana federal court ordered a $9 billion penalty against Takeda and its business partner Eli Lilly and Company after a jury found that the defendants hid evidence about Actos’ link with cancer.
Consumers who took Actos and were diagnosed with bladder cancer are filing lawsuits against Japan-based Takeda and its American business partner Eli Lilly and Company. Family members of consumers who died from bladder are cancer are similarly filing claims to hold Takeda accountable.
Always discuss medical symptoms with your doctor before taking any actions that may impact your health. For those who take Actos, possible symptoms or signs of bladder cancer may include: